B
Ben Comer
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
OCT 5
OCT 12
OCT 19
Jun 3, 2026
The Editors’ Roundtable: A Midyear Look At The 2026 Life Sciences Industry
7:00

Jeff BuguliskisGUEST
Uh, I think, you know, some of the, you know, the geopolitical events that have happened, um, have, you know, are really taking an effect when it comes to the outsourcing.
B
7:15Ben ComerGUEST
It's interesting that there's, uh, this uncertainty as, as Jeff said, um, geopolitical uncertainty.
B
7:25Ben ComerGUEST
Um, but I remember, um, you know, talking about in our last round table, uh, the positives, and I think JP Morgan was really positive this year.
B
7:34Ben ComerGUEST
Uh, in January, there were a lot of high expectations and, and surprisingly, uh, the, the leading biotech indices are, are up about, uh, a little over double digits for the first five months of the year.
28 MINS LATER
